3D model (JSmol)
|Molar mass||392.404 g/mol|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|what is ?)(|
SN-38 is an antineoplastic drug. It is the active metabolite of irinotecan (an analog of camptothecin - a topoisomerase I inhibitor) but has 1000 times more activity than irinotecan itself. In vitro cytotoxicity assays show that the potency of SN-38 relative to irinotecan varies from 2- to 2000-fold.
Interactive pathway map
Click on genes, proteins and metabolites below to link to respective articles. [§ 1]
- NK012, a nanodevice formulation of SN-38
- Sacituzumab govitecan, an antibody-drug conjugate that uses SN-38 as the cytotoxic drug.
- O'Dwyer PJ, Catalano RB (October 2006). "Uridine diphosphate glucuronosyltransferase (UGT) 1A1 and irinotecan: practical pharmacogenomics arrives in cancer therapy". J. Clin. Oncol. 24 (28): 4534–8. PMID 17008691. doi:10.1200/JCO.2006.07.3031.
|This oncology article is a stub. You can help Wikipedia by expanding it.|